The contemporary cardiology workplace is fraught with hostility, including discrimination and harassment, according to new data from a global survey. A very low response rate, however, raises questions as to why clinicians refrained from participating in the project.
Also this week, the American College of Cardiology and American Heart Association (ACC/AHA), released a consensus report on professionalism and ethics that potentially could help rectify many of the issues hindering physician well-being in the workplace.
The survey, published in the May 18, 2021, issue of the
Journal of the American College of Cardiology, is far from the first to document a challenging culture in medicine generally and in cardiology specifically. But lead author Garima Sharma, MD (Johns Hopkins University School of Medicine, Baltimore, MD), told TCTMD it is the first to consolidate international perspectives: from Africa, Asia, the Caribbean, Eastern Europe, the European Union, the Middle East, O
President Biden and Iran’s leaders say they share a common goal: They both want to re-enter the nuclear deal that President Donald J. Trump scrapped three years ago, restoring the bargain that Iran would keep sharp limits on its production of nuclear fuel in return for a lifting of sanctions that have choked its economy. But after five weeks of shadow boxing in Vienna hotel rooms where the two sides pass notes through European intermediaries it has become clear that the old deal, strictly defined, does not work for either of them anymore, at least in the long run.
The psychedelic revolution is coming. Psychiatry may never be the same
By Andrew Jacobs New York Times,Updated May 9, 2021, 9:24 p.m.
Email to a Friend
Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies, a nonprofit research group, at his home in Belmont, Mass. on April 9, 2021. A new study shows that MDMA, the illegal drug known as Ecstasy or Molly, can bring relief when paired with talk therapy to those with severe post-traumatic stress disorder.RONY LUONG/NYT
Itâs been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics researcher, dropped his first hit of acid in college and decided to dedicate his life to the healing powers of mind-altering compounds. Even as anti-drug campaigns led to the criminalization of Ecstasy, LSD and magic mushrooms, and drove most researchers from the field, Doblin continued his quixotic crusade with financial help from his parents.
Compugen Announces Expansion of Research Collaboration with Johns Hopkins University for a Novel Myeloid Target Discovered by Compugen
USA - English
News provided by
Share this article
HOLON, Israel, May 10, 2021 /PRNewswire/
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has expanded its research collaboration with Johns Hopkins University to include studies investigating the biology of a novel myeloid target that was computationally-discovered by Compugen. Initial preclinical studies demonstrate the potential of this target to serve as a novel myeloid immunomodulator, with significant tumor growth inhibition observed upon genetic deletion in
Updated:
May 10, 2021 14:35 IST Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict COVID-19 safety precautions, even after vaccination, said study lead author
Share Article
AAA
A health worker administers the COVID-19 vaccine at a PHC in Vijayawada | Photo Credit: GIRI KVS Based on our findings, we recommend that transplant recipients and other immunocompromised patients continue to practice strict COVID-19 safety precautions, even after vaccination, said study lead author
Although two doses of a COVID-19 vaccine confer some protection for people who have received solid organ transplants, it s still not enough to enable them to dispense with masks, physical distancing and other safety measures, according to a study.